If you have been reading about PPARδ agonist and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Also called GW501516 and endurobol. |
| Chemical formula | C21H18F3NO3S2 | Molecular weight about 453.5 g/mol. |
| Appearance | White to off-white solid | Form depends on synthesis and purity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, protected from light | Common for research chemicals. |
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
=== In pharmacology === Bioavailability is a term used to describe the percentage of an administered dose of a xenobiotic that reaches the systemic circulation unchanged. It is denoted by the letter f (or, if expressed in percent, by F).
==== Merchant wholesalers ==== These firms take ownership of inventory and earn a margin by buying and reselling. They can specialize by product (food, pharmaceuticals, industrial inputs) or by customer segment (construction trades, hospitality, public sector).
As pointed out by Peter Ward and Donald Brownlee in their book The Life and Death of Planet Earth, the process of ocean loss has only been documented twice: first during the Apollo 16 Moon mission, when the mission's astronauts observed Earth using a unique Carruthers camera, and again during the 1990s through studies based on observations made by astronauts aboard the Space Shuttle. Saturn's moon Titan has a very weak cold trap that is only able to retain some of its atmospheric methane. Thus, it has been suggested that Titan is the closest analog to what Earth's atmosphere will look like as Earth's cold trap fails, with methane instead of water and hydrocarbon products of photochemistry instead of oxygen and ozone. Cold traps are thought to function for oxygen on Ganymede.
== Structural studies == As of late 2007, 9 structures have been solved for this class of enzymes, with PDB accession codes PDB: 1K4K, PDB: 1K4M, PDB: 1KAM, PDB: 1KAQ, PDB: 1YUL, PDB: 1YUM, PDB: 1YUN, PDB: 2H29, and PDB: 2H2A.
=== Tom Wolsey === Tom Wolsey (Harry Hadden-Paton) is the newly-appointed CEO of Pierpoint, brought on to help steer the firm through its debt crisis. Tom assembles an emergency committee of senior executives to help salvage Pierpoint when its stock plummets the day of its 150th anniversary. After several failed attempts to find a buyer for the firm, Eric finally brokers a sale with Al-Mi'raj, a firm representing the Egyptian sovereign wealth fund. Tom is fired as CEO because the Egyptian government would not approve of his homosexuality.
Sources: en.wikipedia.org
A study by Kim et al. investigated the nutritional value of S. mutilans hoping to extend the application of this species from traditional medicine only. Nutritional analysis on this species found that it is high in crude protein (around 55%) and fat (around 26-30%). Essential amino acids were present, with lysine being the most common (around 3.5% of all essential amino acids), and glutamic acid being the most common nonessential amino acid present in the centipede (around 7% of all nonessential amino acids). Unsaturated fatty acids were also present, with oleic acid being the most common (around 41-48%). Mercury was found, but the concentration was below food safety limits. Pathogenic microorganisms were not found in the centipede samples. From these findings, the researchers suggested that S. mutilans has the potential to be a medicine and food ingredient.
== Controversies == In December 2015, a settlement was reached that applies to protein shakes and beverages that include MuscleTech. In June 2016, MuscleTech's parent Iovate was sued by rival Hi-Tech Pharmaceuticals over Racketeer Influenced and Corrupt Organizations and protein spiking allegations. In September 2019, MuscleTech was sued by a consumer claiming that a MuscleTech dietary supplement (Platinum 100% BCAA 8:1:1) decreased muscle protein synthesis. In May 2020, a MuscleTech product made in the U.S. was linked to a death in Spain. In April 2022, a lawsuit was filed alleging containers of MuscleTech powder supplements were sold half empty. In June 2025, Malaysian bodybuilding supplement retailer Muscle Mania Club claimed that there are only 9.9g of protein in Nitro-Tech, well below the 30g of protein claimed on the bottle, after they sent a sample for a third party lab testing done in Malaysia. Iovate responded by producing its own test results done by Eurofins that showed protein content meeting the 30g label claim and added that Muscle Mania Club is not an authorized MuscleTech reseller.
Everyone has the right to food and water, and under the Charter of Fundamental Rights of the EU "the improvement of the quality of the environment must be integrated into the policies of the Union". The Common Agricultural Policy's origins lay in ensuring that all farm workers had fair wages and everyone had food, since in 1960 a third of employment and a fifth of GDP was in agriculture, and after WW2 Europe had been on the brink of starvation. In 2020, the agricultural workforce was 4.2% of the EU total. The CAP's objectives are still to increase production, "a fair standard of living for the agricultural community", to stabilise markets and supplies, and "reasonable prices" for consumers. In 2021, the CAP was 33.1% of the entire EU budget, at €55.1 billion, however there are no requirements for subsidies to be used so that farm workers (as opposed to owners) have fair pay scales, few requirements for rural development, and minimal standards for environmental improvement.
Darlene was granted power of attorney over Bev's finances, until late in the second season of The Conners, when the 94-year-old Bev, angry that Darlene allowed Jackie and Becky to re-open the Lunch Box restaurant (an asset Bev somehow secretly retained), revoked Darlene having power of attorney.
They are also sufficiently common that "passage" birds in their first year are relatively easy to trap. Wild-caught kestrels "tame down" fairly quickly. They will usually be eating from a falconer's hand the day after capture, be training within a week, and be ready to hunt in three to five weeks. A very tame American kestrel will allow itself to be picked up around the body with one hand while accepting tidbits from the other hand. Such tameness is very useful when checking or treating the bird for injury or illness. Migratory raptors native to the United States are protected by the Migratory Bird Treaty Act of 1918, so American kestrels are illegal to possess without a permit (such as a falconry permit) in the United States, Canada, and Mexico.
Sources: en.wikipedia.org
Antimicrobial peptides generally have a net positive charge, allowing them to interact with the negatively charged molecules exposed on bacteria and cancer cell surfaces, such as phospholipid phosphatidylserine, O-glycosylated mucins, sialylated gangliosides, and heparin sulfates. The mechanism of action of these peptides varies widely but can be simplified into two categories: membranolytic and non-membranolytic antimicrobial peptides. The disruption of membranes by membranolytic antimicrobial peptides can be described by four models:
=== Functional brain imaging === Usually the gamma-emitting tracer used in functional brain imaging is 99mTc-HMPAO (hexamethylpropylene amine oxime, exametazime). The similar 99mTc-EC tracer may also be used. These molecules are preferentially distributed to regions of high brain blood flow, and act to assess brain metabolism regionally, in an attempt to diagnose and differentiate the different causal pathologies of dementia. When used with the 3-D SPECT technique, they compete with brain FDG-PET scans and fMRI brain scans as techniques to map the regional metabolic rate of brain tissue.
At a White House press briefing on September 22, 2025, President Trump, joined by Kennedy and other senior officials, said the FDA would revise drug labels to discourage the use of acetaminophen (sold under the brand name Tylenol) during pregnancy, citing a possible link to autism. Medical and public health experts disputed the claim. Steven J. Fleischman, president of the American College of Obstetricians and Gynecologists, wrote, "It is highly unsettling that our federal health agencies are willing to make an announcement that will affect the health and well-being of millions of people without the backing of reliable data." A month later, on October 29, Kennedy retracted his statements from the press conference, stating that acetaminophen use in pregnancy is not linked to autism. On November 10, 2025, in response to President Trump's false claim, a 2025 British Medical Journal umbrella review was fast-tracked and confirmed no convincing evidence that paracetamol (acetaminophen) use during pregnancy increases the risk of autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD) in children. The review, led by researchers at the University of Liverpool, analysed nine systematic reviews covering 40 observational studies and concluded that any apparent associations were likely due to family genetics, maternal health, or other shared factors rather than the drug itself.
=== Health === According to the House of Commons survey of female genital mutilation, in the year to 31 March 2016, Brent represented the highest number of attendees, by current residence or visiting location, to medical services, at 1,250, 545 more than the next-highest local authority, Bristol. In 2015, the BBC reported that some wards of Brent and four other London boroughs had rates of tuberculosis over ten times the national average, and higher than rates seen in Iraq and Rwanda.
Sources: en.wikipedia.org
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.
It activates PPARδ, a nuclear receptor that influences gene expression related to lipid and energy metabolism. Animal studies show changes in endurance and lipid levels. Human effects and risks are not well established.
No, cardarine is not a steroid. It belongs to a different chemical class, the PPARδ agonists. It is also not a selective androgen receptor modulator.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.